Summary
We re-examined 69 of the 70 patients entering the two independent Steno Studies of effects of improved metabolic control on progression of late diabetic complications. They were analysed according to an intent to treat after follow-up for 8 years (Steno Study 1) and 5 years (Steno Study 2). The glycaemic control had improved in the insulin infusion group compared with the conventional treatment group (mean HbA1c) by 2.0±0.6% vs 0.7±1.2 in Steno Study 1 and by 1.8±1.2% vs 0.4±1.3 (p<0.01) in Steno Study 2. In the insulin infusion groups three patients had died during episodes of ketoacidosis. These were not caused by malfunction of the insulin infusion pumps. In the conventional treatment groups, three patients suffered five cardiovascular events causing two deaths. From the sixth month of Steno Study 1 the annual change of the glomerular filtration rate was −3.7 (−5.4 to −2.0) ml·min−1·1.73 m−2 vs −1.0 (−2.1 to −0.1) (conventional vs insulin infusion group, mean (95% confidence interval, p<0.01)). The change in urinary albumin excretion was associated with the glycaemic control (n=69, r=0.49, p<0.0002). No progression was observed among 32 patients with low range microalbuminuria (30 to 99 mg/24 h). Among the 19 patients with an initial albumin excretion between 100 and 300 mg/24 h, progression of complications was more frequent during conventional treatment (n=10) vs insulin infusion (n=9): Clinical nephropathy (10 of 10 vs 2 of 9, p<0.01) and arterial hypertension (7 of 10 vs 1 of 9, p<0.01). The glomerular filtration rate declined during conventional treatment by −23 (−42 to −4) ml·mm−1·1.73 m−2 (p<0.05) but not during insulin infusion (−13 (−31 to 5) NS). These results suggest that patients at risk of nephropathy should be offered near normal glycaemic control in order to preserve their kidney function.
Article PDF
Similar content being viewed by others
References
Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T, Steno Study Group (1985) Two years' experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 34 [Suppl 3]: 74–79
Feldt-Rasmussen B, Mathiesen ER, Deckert T (1986) Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet II: 1300–1304
Beck-Nielsen H, Richelsen B, Mogensen CE, Olsen T, Ehlers N, Nielsen CB, Charles P (1985) Effect of insulin pump treatment for 1 year on renal function and retinal morphology in patients with IDDM. Diabetes Care 8: 585–589
Wiseman M, Saunders AJ, Keen H, Viberti GC (1985) Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 312: 617–621
Bending JJ, Viberti GC, Watkins PJ, Keen H (1986) Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control. Br Med J 292: 83–86
Raskin P, Pietri AO, Unger R, Shannon WA (1983) The effect of diabetic control on the width of skeletal-muscle capillary basement membrane in patients with type 1 diabetes mellitus. N Engl J Med 309: 1546–1550
Viberti GC, Bilous RW, Mackintosh D, Bending JJ, Keen H (1983) Long-term correction of hyperglycemia and progression of renal failure in insulin-dependent diabetes. Br Med J 286: 598–602
Davies AG, Price DA, Houlton CA, Burn JL, Fielding BA, Poslethwaite RJ (1984) Continuous subcutaneous insulin infusion in diabetes mellitus. Arch Dis Child 59: 1027–1033
Friberg TR, Rosenstock J, Sanborn G, Vaghefi A, Raskin P (1985) The effect of long-term near normal glycemic control on mild diabetic retinopathy. Ophthalmology 92: 1051–1058
Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E, Sandvik L, Aagenaes Ø (1986) Effect of near-normo glycemia for two years on progression of early diabetic retinopathy, nephropathy and neuropathy: the Oslo Study. Br Med J 293: 1195–1199
Reichard P, Rosenqvist U (1989) Nephropathy is delayed by intensified insulin treatment in patients with insulin-dependent diabetes mellitus and retinopathy. J Int Med 226: 81–87
Feldt-Rasmussen B, Mathiesen ER, Hegedüs L, Deckert T (1986) Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy. N Engl J Med 314: 665–670
Svendsen PA, Christiansen JS, Søegaard U, Welinder BS, Nerup J (1980) Rapid changes in chromatographically determined haemoglobin A1c, induced by short-term changes in glucose concentration. Diabetologia 19: 130–136
Mancini G, Carbonara AO, Heremans JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2: 301–305
Feldt-Rasmussen B, Dinesen B, Deckert M (1985) Enzyme immunoassay — an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45: 539–544
Broechner-Mortensen J, Giese J, Rossing N (1969) Renal insulin clearance versus total plasma clearance of 51Cr-EDTA. Scand J Clin Lab Invest 23: 301–305
Mathiesen ER, Oxenbøll R, Johansen K, Svendsen PA, Deckert T (1984) Incipient nephropathy in Type 1 (insulin-dependent) diabetes. Diabetologia 26: 406–410
Deckert T, Lauritzen T, Parving H-H, Christiansen JS, Steno Study Group (1984) Effect of two years of strict metabolic control on kidney function in long-term insulin-dependent diabetics. Diab. Nephropathy 3: 6–10
Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet I: 1430–1432
Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent diabetic patients. N Engl J Med 311: 89–93
Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage. The Steno Hypothesis. Diabetologia 32: 219–226
Doft BH, Kingsley LA, Orchard TJ, Kuller L, Drasch A, Becker D (1984) The association between long-term diabetic control and early retinopathy. Ophthalmology 91: 763–769
Weber B, Burger W, Hartmann R, Howener R, Howener G, Malchuo R, Oberdisse U (1986) Risk factors for the development of retinopathy in children and adolescents with Type 1 diabetes mellitus. Diabetologia 29: 23–29
Nørgaard K, Storm B, Graae M, Feldt-Rasmussen B (1989) Elevated albumin excretion and retinal changes in children with type 1 diabetes are related to long-term poor metabolic control. Diabetic Medicine 6: 325–328
McCane DR, Atkinson AB, Hadden DR, Archer DB, Kennedy L (1989) Long-term glycaemic control and diabetic retinopathy. Lancet II: 824–828
Nyberg G, Blohmé G, Nordén G (1987) Impact of metabolic control in progression of clinical diabetic nephropathy. Diabetologia 30: 82–86
Rønn B, Mathiesen ER, Vang L, Lørup B, Deckert T (1987) Evaluation of insulin pump treatment under routine conditions. Diab Res Clin Pract 3: 191–196
Snorgaard O, Eskildsen PC, Vadstrup S, Nerup J (1982) Epidemiological aspects of diabetic ketoacidosis in Denmark (Copenhagen county). Acta Endocrinol 100 [Suppl 247]: 56A
Knight G, Boulton AJM, Drury J, Gamsu DS, Moses JL, Bradley C, Ward JD (1984) A feasibility study of the use of continuous subcutaneous insulin infusion in a diabetic clinic: patients' choice of treatment, Diab Med 1: 267–272
The Kroc Collaborative Study Group (1984) Blood glucose control and evaluation of diabetic retinopathy and albuminuria. N Engl J Med 6: 365–372
Peden NR, Braaten JT, McKendry R (1984) Diabetic ketoacidosis during long-term treatment with continuous subcutaneous insulin infusion. Diabetes Care 7: 1–5
Mecklenburg RS, Benson EA, Benson JW et al. (1984) Acute complications associated with insulin infusion pump therapy. J Am Med Assoc 252: 2365–2369
Sonnenberg GE, Mühlhauser I, Chantelau E, Berger M (1985) Incidence of ketoacidosis and severe hypoglycaemia in conventional and CSII treated Type 1 diabetic patients. Diabetes 34 [Suppl 1]: 34A
Teutsch SM, Herman WH, Dwyer DM, Lane JM (1987) Mortality among diabetic patients using continuous subcutaneous insulin infusion. N Engl J Med 310: 361–368
DCCT Study Group (1987) Diabetes Control and Complications Trial (DCCT): Results of feasibility study. Diabetes Care 10: 1–19
Mogensen CE (1982) Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285: 658–688
Parving H-H, Andersen AR. Smidt UM, Hommel E, Mathiesen ER, Svendsen PAa (1987) Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294: 1443–1447
Mathiesen ER, Borch-Johnsen K, Jensen DV, Deckert T (1989) Improved survival in patients with diabetic nephropathy. Diabetologia 32: 884–886
Parving H-H, Hommel E (1989) Prognosis in diabetic nephropathy. Br Med J 299: 230–233
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Feldt-Rasmussen, B., Mathiesen, E.R., Jensen, T. et al. Effect of improved metabolic control on loss of kidney function in Type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 34, 164–170 (1991). https://doi.org/10.1007/BF00418270
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00418270